ICD-10-CM Code Q86.8

Other congenital malformation syndromes due to known exogenous causes

Version 2020 Billable Code POA Exempt

Valid for Submission

Q86.8 is a billable code used to specify a medical diagnosis of other congenital malformation syndromes due to known exogenous causes. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code Q86.8 might also be used to specify conditions or terms like congenital malformation due to cytotoxic agents, disorder of fetal abdominal region, fetal aminopterin syndrome, fetal benzodiazepine syndrome, fetal carbamazepine syndrome, fetal cocaine syndrome, etc The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

ICD-10:Q86.8
Short Description:Oth congen malform syndromes due to known exogenous causes
Long Description:Other congenital malformation syndromes due to known exogenous causes

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code Q86.8 are found in the index:


Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Congenital malformation due to cytotoxic agents
  • Disorder of fetal abdominal region
  • Fetal aminopterin syndrome
  • Fetal benzodiazepine syndrome
  • Fetal carbamazepine syndrome
  • Fetal cocaine syndrome
  • Fetal diethylstilbestrol syndrome
  • Fetal iodine syndrome
  • Fetal methyl mercury syndrome
  • Fetal minoxidil syndrome
  • Fetal misoprostol syndrome
  • Fetal or neonatal effect of maternal use of antihypertensive drug
  • Fetal or neonatal effect of placental or breast transfer of anticonvulsant
  • Fetal or neonatal effect of placental or breast transfer of anticonvulsant
  • Fetal or neonatal effect of placental or breast transfer of anticonvulsant
  • Fetal primidone syndrome
  • Fetal toluene syndrome
  • Fetal trimethadione syndrome
  • Fetal valproate syndrome
  • Fetus with drug damage
  • Fetus with drug damage
  • Indomethacin embryofetopathy
  • Maternal PKU fetal effect
  • Methimazole embryofetopathy
  • Multiple malformation syndrome due to non-infectious environmental agents
  • Mycophenolate mofetil embryopathy
  • Narcotic embryopathy
  • Phenobarbital embryopathy
  • Renal dysplasia due to fetal exposure to angiotensin converting enzyme inhibitor
  • Retinoid embryopathy
  • Thalidomide embryopathy syndrome

Present on Admission (POA)

Q86.8 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here .

CMS POA Indicator Options and Definitions
POA Indicator CodePOA Reason for CodeCMS will pay the CC/MCC DRG?
YDiagnosis was present at time of inpatient admission.YES
NDiagnosis was not present at time of inpatient admission.NO
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.NO
WClinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.YES
1Unreported/Not used - Exempt from POA reporting. NO

Convert Q86.8 to ICD-9

  • 760.79 - Nox sub NEC aff NB/fetus (Approximate Flag)

Code Classification

  • Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
    • Other congenital malformations (Q80-Q89)
      • Congen malform syndromes due to known exogenous causes, NEC (Q86)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Information for Patients


Birth Defects

A birth defect is a problem that happens while a baby is developing in the mother's body. Most birth defects happen during the first 3 months of pregnancy. One out of every 33 babies in the United States is born with a birth defect.

A birth defect may affect how the body looks, works or both. Some birth defects like cleft lip or neural tube defects are structural problems that can be easy to see. To find others, like heart defects, doctors use special tests. Birth defects can range from mild to severe. Causes can include

  • Genetics
  • Exposures to medicines or chemicals. For example, alcohol abuse can cause fetal alcohol syndrome.
  • Infections during pregnancy
  • Certain medicines. Before you get pregnant, talk to your health care provider about any medicines you take.
  • Not getting enough of certain nutrients. For example, not getting enough folic acid before and during pregnancy is a key factor in causing neural tube defects.

For most birth defects, the cause is unknown.

Health care providers can diagnose certain birth defects during pregnancy, with prenatal tests. That's why it important to get regular prenatal care. Other birth defects may not be found until after the baby is born. Sometimes the defect is obvious right away. Other times, the health care provider may not discover it until later in life.

Babies with birth defects often need special care and treatments. The treatments may include surgery, medicines, assistive devices, and therapies.

Centers for Disease Control and Prevention


[Learn More]